Pharmaceutical agents

CAFC
  • US 5,319,097 A
  • Filed: 12/11/1991
  • Issued: 06/07/1994
  • Est. Priority Date: 12/12/1990
  • Status: Expired due to Term
First Claim
Patent Images

1. A physical form of N-[4-[5-(cyclopentyloxycarbonyl)amino-1-methylindol-3-yl-methyl]-3methoxybenzoyl]-2-methylbenzenesulphonamide which physical form is a monohydrate of N-[4-[5-(cyclopentyloxycarbonyl)amino-1-methylindol-3-yl-methyl]-3-methoxybenzoyl]-2-methylbenzene-sulphonamide which is crystalline, has an infra-red spectrum (0.5% in KBr) having sharp peaks at 3560, 1690, 1660, 1540, 1440, 1165, 880 and 858cm-1, and an X-ray powder diffraction pattern having peaks at 2θ

  • =10.0°

    , 11.2°

    , 14.6°

    , 19.8°

    and 23.0°

    .

View all claims
    ×
    ×

    Thank you for your feedback

    ×
    ×